Komori
Governance4570Immuno-Biological Laboratories Co.,Ltd.Pharmaceuticals

Notice Regarding Membership Status in the Financial Accounting Standards Foundation and the Company’s Views on Membership

The company disclosed that it is not a member of the Financial Accounting Standards Foundation and explained that it currently has no plans to join. It plans to address changes in accounting standards through coordination with its audit firm and participation in training seminars.

Worth reading
—
Scored from 0 of 5 sections
Direction
Neutral
Direction inferred from the company’s description.
Scale
—
Displayed only when the document provides numerical figures.
Wording
Conditional
How definitive the wording is.

Contents of this filing

This filing does not state the corporate governance structure or the composition of the board of directors.

Contents of this filing
ItemDetails
Items this document does not state (8)
Corporate Governance StructureNumber of directorsNumber of independent officersCommitteePolicy on cross-shareholdingsTakeover defensesControlling shareholderChanges this time

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

The company is refraining from joining as it works to contain expenses and other costs to ensure stable management. It will address accounting standards and related matters through coordination and information sharing with its audit firm and participation in accounting and tax training seminars.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
Notice Regarding Membership Status in the Financial Accounting Standards Foundation and the Company’s Views on Membership | Immuno-Biological Laboratories Co.,Ltd. (4570) timely disclosure | Komori